Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 17 | 2022 | 166 | 2.630 |
Why?
|
| Central Nervous System | 9 | 2015 | 135 | 1.780 |
Why?
|
| Receptors, Immunologic | 5 | 2011 | 61 | 1.320 |
Why?
|
| Membrane Glycoproteins | 5 | 2011 | 211 | 1.200 |
Why?
|
| Macrophages | 9 | 2018 | 439 | 1.140 |
Why?
|
| Lipopolysaccharides | 5 | 2015 | 220 | 0.820 |
Why?
|
| T-Lymphocytes | 5 | 2021 | 357 | 0.800 |
Why?
|
| Brain | 11 | 2021 | 1346 | 0.700 |
Why?
|
| Central Nervous System Infections | 2 | 2013 | 4 | 0.680 |
Why?
|
| Toxoplasma | 3 | 2021 | 9 | 0.660 |
Why?
|
| Chemokine CCL21 | 5 | 2021 | 11 | 0.640 |
Why?
|
| Mice | 25 | 2021 | 5913 | 0.610 |
Why?
|
| Interferon-gamma | 6 | 2011 | 250 | 0.600 |
Why?
|
| Neuroglia | 3 | 2013 | 124 | 0.600 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 1371 | 0.580 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2010 | 259 | 0.580 |
Why?
|
| Toxoplasmosis, Cerebral | 2 | 2021 | 9 | 0.570 |
Why?
|
| Head Injuries, Closed | 1 | 2016 | 2 | 0.550 |
Why?
|
| Animals | 33 | 2021 | 15081 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 14 | 2018 | 1609 | 0.540 |
Why?
|
| Cytokines | 3 | 2017 | 602 | 0.530 |
Why?
|
| Central Nervous System Diseases | 2 | 2007 | 29 | 0.530 |
Why?
|
| Immune System | 2 | 2007 | 41 | 0.500 |
Why?
|
| Lymphocyte Activation | 2 | 2013 | 236 | 0.490 |
Why?
|
| Cell Transplantation | 1 | 2013 | 3 | 0.470 |
Why?
|
| Monocytes | 1 | 2015 | 257 | 0.460 |
Why?
|
| Epilepsy | 1 | 2013 | 43 | 0.450 |
Why?
|
| Chemotaxis | 1 | 2013 | 60 | 0.430 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 481 | 0.430 |
Why?
|
| Nerve Tissue Proteins | 2 | 2007 | 360 | 0.420 |
Why?
|
| Chemokines | 1 | 2013 | 97 | 0.410 |
Why?
|
| Ornithine Decarboxylase | 1 | 2011 | 10 | 0.390 |
Why?
|
| Putrescine | 1 | 2011 | 25 | 0.380 |
Why?
|
| Alzheimer Disease | 3 | 2017 | 905 | 0.380 |
Why?
|
| Immunotherapy, Active | 1 | 2010 | 1 | 0.370 |
Why?
|
| Chemokine CCL2 | 2 | 2011 | 85 | 0.370 |
Why?
|
| Amyloid | 1 | 2010 | 54 | 0.360 |
Why?
|
| Macrophage Activation | 1 | 2009 | 56 | 0.330 |
Why?
|
| Cells, Cultured | 6 | 2017 | 1518 | 0.330 |
Why?
|
| Encephalitis | 2 | 2006 | 42 | 0.320 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2007 | 54 | 0.310 |
Why?
|
| Mice, Transgenic | 5 | 2016 | 617 | 0.310 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 1015 | 0.300 |
Why?
|
| Autoimmune Diseases | 2 | 2007 | 57 | 0.300 |
Why?
|
| Neuroimmunomodulation | 1 | 2007 | 13 | 0.290 |
Why?
|
| RNA, Messenger | 4 | 2018 | 1207 | 0.290 |
Why?
|
| Gene Expression | 2 | 2009 | 674 | 0.280 |
Why?
|
| Blotting, Northern | 4 | 2010 | 150 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 190 | 0.280 |
Why?
|
| Immune Tolerance | 1 | 2006 | 65 | 0.280 |
Why?
|
| Gliosis | 1 | 2006 | 24 | 0.280 |
Why?
|
| Multiple Sclerosis | 2 | 2006 | 45 | 0.280 |
Why?
|
| Brain Diseases | 1 | 2006 | 32 | 0.280 |
Why?
|
| Immunity, Innate | 2 | 2018 | 149 | 0.260 |
Why?
|
| In Situ Hybridization | 4 | 2010 | 129 | 0.250 |
Why?
|
| Neuritis | 1 | 2003 | 2 | 0.240 |
Why?
|
| Pneumonia | 2 | 2018 | 54 | 0.230 |
Why?
|
| Killer Cells, Natural | 1 | 2003 | 92 | 0.220 |
Why?
|
| Transcription Factors | 1 | 2007 | 681 | 0.210 |
Why?
|
| Humans | 19 | 2021 | 37093 | 0.210 |
Why?
|
| Mice, Knockout | 8 | 2021 | 933 | 0.210 |
Why?
|
| Osteonectin | 1 | 2021 | 7 | 0.190 |
Why?
|
| Astrocytes | 4 | 2015 | 255 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2021 | 400 | 0.190 |
Why?
|
| Antigen Presentation | 3 | 2006 | 54 | 0.180 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 115 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 623 | 0.170 |
Why?
|
| Spine | 1 | 2018 | 12 | 0.160 |
Why?
|
| Obesity | 2 | 2018 | 1067 | 0.160 |
Why?
|
| Inflammation | 3 | 2015 | 618 | 0.160 |
Why?
|
| Hypothalamus | 1 | 2018 | 129 | 0.150 |
Why?
|
| Brain Stem | 1 | 2018 | 50 | 0.150 |
Why?
|
| Allergens | 1 | 2018 | 63 | 0.150 |
Why?
|
| Congresses as Topic | 1 | 2017 | 42 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 37 | 0.140 |
Why?
|
| Demyelinating Diseases | 2 | 2007 | 15 | 0.140 |
Why?
|
| Fungi | 1 | 2018 | 89 | 0.140 |
Why?
|
| Sex Characteristics | 1 | 2018 | 230 | 0.140 |
Why?
|
| Receptors, CCR7 | 2 | 2021 | 11 | 0.140 |
Why?
|
| Minority Groups | 1 | 2021 | 596 | 0.130 |
Why?
|
| Inservice Training | 1 | 2015 | 33 | 0.130 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 205 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2013 | 1908 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 218 | 0.130 |
Why?
|
| Adipokines | 1 | 2015 | 24 | 0.130 |
Why?
|
| Catecholamines | 1 | 2015 | 44 | 0.130 |
Why?
|
| Nerve Degeneration | 2 | 2006 | 107 | 0.120 |
Why?
|
| Phagocytosis | 2 | 2015 | 69 | 0.120 |
Why?
|
| Neurons | 3 | 2021 | 1175 | 0.120 |
Why?
|
| Bone Marrow Transplantation | 2 | 2012 | 15 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 121 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 123 | 0.120 |
Why?
|
| Interleukin-10 | 2 | 2018 | 75 | 0.110 |
Why?
|
| Succinimides | 1 | 2013 | 10 | 0.110 |
Why?
|
| Fluoresceins | 1 | 2013 | 27 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2015 | 121 | 0.110 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2013 | 14 | 0.110 |
Why?
|
| Chemokine CCL19 | 2 | 2010 | 5 | 0.110 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2012 | 2 | 0.100 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 181 | 0.100 |
Why?
|
| Huntington Disease | 1 | 2012 | 27 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 81 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2013 | 399 | 0.100 |
Why?
|
| Spermidine | 1 | 2011 | 33 | 0.100 |
Why?
|
| Injections, Intraventricular | 1 | 2011 | 64 | 0.100 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 22 | 0.090 |
Why?
|
| Spermine | 1 | 2011 | 64 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 91 | 0.090 |
Why?
|
| Toxoplasmosis | 1 | 2010 | 2 | 0.090 |
Why?
|
| Time Factors | 2 | 2013 | 1742 | 0.090 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 13 | 0.090 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 50 | 0.090 |
Why?
|
| Cerebellum | 1 | 2010 | 73 | 0.090 |
Why?
|
| RNA | 2 | 2009 | 241 | 0.090 |
Why?
|
| Male | 6 | 2018 | 20025 | 0.090 |
Why?
|
| Antigen-Presenting Cells | 2 | 2006 | 30 | 0.090 |
Why?
|
| Reverse Transcription | 1 | 2009 | 18 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2002 | 1180 | 0.090 |
Why?
|
| Lymphotoxin-beta | 1 | 2009 | 3 | 0.090 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2009 | 16 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2002 | 1568 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 626 | 0.080 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2008 | 2 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2009 | 113 | 0.080 |
Why?
|
| Bone Diseases | 1 | 2008 | 18 | 0.080 |
Why?
|
| Models, Neurological | 1 | 2009 | 128 | 0.080 |
Why?
|
| Dementia, Vascular | 1 | 2008 | 36 | 0.080 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2007 | 5 | 0.080 |
Why?
|
| Acute Disease | 1 | 2007 | 147 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1198 | 0.070 |
Why?
|
| Interleukin-17 | 1 | 2007 | 53 | 0.070 |
Why?
|
| Myelin Sheath | 2 | 2007 | 48 | 0.070 |
Why?
|
| Computational Biology | 1 | 2009 | 293 | 0.070 |
Why?
|
| Chemokines, CXC | 2 | 2007 | 35 | 0.070 |
Why?
|
| Cell Count | 2 | 2007 | 135 | 0.070 |
Why?
|
| Colitis | 1 | 2007 | 65 | 0.070 |
Why?
|
| Cell Death | 2 | 2006 | 267 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 286 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2006 | 53 | 0.070 |
Why?
|
| AIDS Dementia Complex | 1 | 2006 | 102 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2007 | 131 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2006 | 95 | 0.060 |
Why?
|
| Rats | 2 | 2003 | 3483 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2006 | 219 | 0.060 |
Why?
|
| Cell Compartmentation | 1 | 2004 | 13 | 0.060 |
Why?
|
| Cytoprotection | 1 | 2004 | 36 | 0.060 |
Why?
|
| Motor Neurons | 1 | 2004 | 83 | 0.060 |
Why?
|
| Cell Survival | 2 | 2004 | 864 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2006 | 513 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 1 | 2002 | 23 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2002 | 130 | 0.050 |
Why?
|
| Leukocytes | 1 | 2002 | 72 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 325 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2002 | 118 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 408 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 188 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 207 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2002 | 191 | 0.050 |
Why?
|
| Ovary | 1 | 2002 | 108 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 53 | 0.050 |
Why?
|
| Host-Parasite Interactions | 1 | 2021 | 42 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2021 | 57 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2002 | 435 | 0.050 |
Why?
|
| Testis | 1 | 2002 | 187 | 0.050 |
Why?
|
| Base Sequence | 1 | 2002 | 997 | 0.050 |
Why?
|
| Antigens, Protozoan | 1 | 2021 | 72 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2006 | 583 | 0.040 |
Why?
|
| Immunization | 2 | 2015 | 92 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 474 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2002 | 366 | 0.040 |
Why?
|
| Research Personnel | 1 | 2021 | 155 | 0.040 |
Why?
|
| Female | 5 | 2018 | 20969 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2006 | 730 | 0.040 |
Why?
|
| Fertility | 1 | 2018 | 59 | 0.040 |
Why?
|
| Hippocampus | 1 | 2002 | 561 | 0.040 |
Why?
|
| Arginase | 1 | 2018 | 13 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2018 | 43 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2018 | 119 | 0.040 |
Why?
|
| Protein Binding | 1 | 2021 | 972 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 115 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2018 | 121 | 0.040 |
Why?
|
| Cell Movement | 1 | 2021 | 571 | 0.040 |
Why?
|
| Allergy and Immunology | 1 | 2017 | 11 | 0.040 |
Why?
|
| Speech | 1 | 2017 | 12 | 0.040 |
Why?
|
| Cuprizone | 2 | 2007 | 5 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2018 | 153 | 0.040 |
Why?
|
| Corpus Callosum | 2 | 2007 | 12 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 1618 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 95 | 0.040 |
Why?
|
| Nootropic Agents | 1 | 2015 | 7 | 0.030 |
Why?
|
| Resistin | 1 | 2015 | 4 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2015 | 15 | 0.030 |
Why?
|
| Thermogenesis | 1 | 2015 | 20 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2009 | 661 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2017 | 308 | 0.030 |
Why?
|
| Hormones | 1 | 2015 | 55 | 0.030 |
Why?
|
| Chemokine CXCL10 | 2 | 2007 | 37 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2015 | 64 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 185 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2015 | 124 | 0.030 |
Why?
|
| Protein Folding | 1 | 2015 | 127 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 204 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 610 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 601 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2010 | 48 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 48 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2009 | 47 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 80 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 325 | 0.020 |
Why?
|
| Apoptosis | 2 | 2007 | 1398 | 0.020 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2007 | 24 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2007 | 45 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2007 | 84 | 0.020 |
Why?
|
| Liver | 1 | 2010 | 479 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2007 | 92 | 0.020 |
Why?
|
| Lung | 1 | 2010 | 446 | 0.020 |
Why?
|
| PPAR alpha | 1 | 2007 | 42 | 0.020 |
Why?
|
| Thiazoles | 1 | 2007 | 74 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 3562 | 0.020 |
Why?
|
| Spleen | 1 | 2007 | 199 | 0.020 |
Why?
|
| Cell Division | 1 | 2007 | 307 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2007 | 63 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 295 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1354 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 237 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2006 | 57 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2004 | 7 | 0.020 |
Why?
|
| Axotomy | 1 | 2004 | 17 | 0.020 |
Why?
|
| Facial Nerve | 1 | 2004 | 10 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 2004 | 20 | 0.020 |
Why?
|
| Antigens | 1 | 2004 | 56 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 1033 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 893 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 2002 | 31 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2002 | 70 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 70 | 0.010 |
Why?
|